Table 1.
Variable | Median (range) |
---|---|
Age (years) | 35.2 (3.4,72.3) |
Follow up (years) | 9.3 (3,31.5) |
Gender (Female) | 37 (56%) |
Prophylactic intent | 14 (21%) |
Known Structural disease | 10 (15%) |
Tumor size (cm) | 1.5 (0.1,7.5) cm |
Node positive | 36 (55%) |
Number of positive nodes | 1 (0,49) |
Persistent biochemical disease* | 36 (55%) |
Preop calcitonin (pg/ml), n=41 | 636 (0,9600) |
Preop CEA (ng/ml), n=17 | 29.4 (0.9,179) |
Post op calcitonin (pg/ml), n=61 | 16 (0,9750) |
Post op CEA (ng/ml), n=45 | 8.4 (0.8,1207) |
Persistent biochemical disease was defined as an elevation in the first postoperative calcitonin level